These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 16543819)

  • 41. A monoclonal antibody (1D12) defines novel distribution patterns of prion protein (PrP) as granules in nucleus.
    Hosokawa T; Tsuchiya K; Sato I; Takeyama N; Ueda S; Tagawa Y; Kimura KM; Nakamura I; Wu G; Sakudo A; Casalone C; Mazza M; Caramelli M; Takahashi H; Sata T; Sugiura K; Baj A; Toniolo A; Onodera T
    Biochem Biophys Res Commun; 2008 Feb; 366(3):657-63. PubMed ID: 18068119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chromatin breakdown during necrosis by serum Dnase1 and the plasminogen system.
    Napirei M; Wulf S; Mannherz HG
    Arthritis Rheum; 2004 Jun; 50(6):1873-83. PubMed ID: 15188364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin.
    Tsirka SE; Bugge TH; Degen JL; Strickland S
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9779-81. PubMed ID: 9275201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle.
    Liang J; Wang W; Sorensen D; Medina S; Ilchenko S; Kiselar J; Surewicz WK; Booth SA; Kong Q
    J Biol Chem; 2012 May; 287(20):16510-20. PubMed ID: 22447932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The fate of the prion protein in the prion/plasminogen complex.
    Kornblatt JA; Marchal S; Rezaei H; Kornblatt MJ; Balny C; Lange R; Debey MP; Hui Bon Hoa G; Marden MC; Grosclaude J
    Biochem Biophys Res Commun; 2003 Jun; 305(3):518-22. PubMed ID: 12763023
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Difference in electrophoretic mobility and plasmic digestion profile between four recombinant fibrinogens, gamma 308K, gamma 308I, gamma 308A, and wild type (gamma 308N).
    Okumura N; Terasawa F; Fujita K; Tozuka M; Ota H; Katsuyama T
    Electrophoresis; 2000 Jul; 21(12):2309-15. PubMed ID: 10939439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Scrapie PrP 27-30 is a sialoglycoprotein.
    Bolton DC; Meyer RK; Prusiner SB
    J Virol; 1985 Feb; 53(2):596-606. PubMed ID: 3918176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene targeting in hemostasis. plasminogen.
    Ploplis VA
    Front Biosci; 2001 Mar; 6():D555-69. PubMed ID: 11229877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular pathogenesis of type I congenital plasminogen deficiency: expression of recombinant human mutant plasminogens in mammalian cells.
    Azuma H; Mima N; Shirakawa M; Miyamoto K; Yamaguchi H; Mitsui T; Shigekiyo T; Saito S
    Blood; 1997 Jan; 89(1):183-90. PubMed ID: 8978291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasminogen and wound healing.
    Rømer J; Bugge TH; Pyke C; Lund LR; Flick MJ; Degen JL; Danø K
    Nat Med; 1996 Jul; 2(7):725. PubMed ID: 8673908
    [No Abstract]   [Full Text] [Related]  

  • 51. Cuts and scrapes? Plasmin heals!
    Vassalli JD; Saurat JH
    Nat Med; 1996 Mar; 2(3):284-5. PubMed ID: 8612225
    [No Abstract]   [Full Text] [Related]  

  • 52. Endoproteolysis of cellular prion protein by plasmin hinders propagation of prions.
    Mays CE; Trinh THT; Telling G; Kang HE; Ryou C
    Front Mol Neurosci; 2022; 15():990136. PubMed ID: 36117913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cellular and Molecular Mechanisms of Prion Disease.
    Sigurdson CJ; Bartz JC; Glatzel M
    Annu Rev Pathol; 2019 Jan; 14():497-516. PubMed ID: 30355150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of Cellular Sialidases Does Not Affect the Sialylation Status of the Prion Protein but Increases the Amounts of Its Proteolytic Fragment C1.
    Katorcha E; Klimova N; Makarava N; Savtchenko R; Pan X; Annunziata I; Takahashi K; Miyagi T; Pshezhetsky AV; d'Azzo A; Baskakov IV
    PLoS One; 2015; 10(11):e0143218. PubMed ID: 26569607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proteolytic processing of the prion protein in health and disease.
    Altmeppen HC; Puig B; Dohler F; Thurm DK; Falker C; Krasemann S; Glatzel M
    Am J Neurodegener Dis; 2012; 1(1):15-31. PubMed ID: 23383379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. α-Cleavage of cellular prion protein.
    Liang J; Kong Q
    Prion; 2012; 6(5):453-60. PubMed ID: 23052041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular interaction between prion protein and GFAP both in native and recombinant forms in vitro.
    Dong CF; Wang XF; Wang X; Shi S; Wang GR; Shan B; An R; Li XL; Zhang BY; Han J; Dong XP
    Med Microbiol Immunol; 2008 Dec; 197(4):361-8. PubMed ID: 18087720
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unaltered prion protein cleavage in plasminogen-deficient mice.
    Barnewitz K; Maringer M; Mitteregger G; Giese A; Bertsch U; Kretzschmar HA
    Neuroreport; 2006 Apr; 17(5):527-30. PubMed ID: 16543819
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro and in vivo neurotoxicity of prion protein oligomers.
    Simoneau S; Rezaei H; Salès N; Kaiser-Schulz G; Lefebvre-Roque M; Vidal C; Fournier JG; Comte J; Wopfner F; Grosclaude J; Schätzl H; Lasmézas CI
    PLoS Pathog; 2007 Aug; 3(8):e125. PubMed ID: 17784787
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purkinje-cell degeneration in prion protein-deficient mice is associated with a cerebellum-specific Doppel protein species signature.
    Al Bersaoui R; Robert I; Lutz Y; Blanc F; Sommermeyer-Leroux G; Shibaguchi H; Aunis D; Fuchs JP
    FEBS Lett; 2005 May; 579(12):2715-21. PubMed ID: 15862314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.